Molecular targets of atypical antipsychotics: From mechanism of action to clinical differences

…, E Cini, M Rossi, PJ McCormick, GU Corsini… - Pharmacology & …, 2018 - Elsevier
The introduction of atypical antipsychotics (AAPs) since the discovery of its prototypical drug
clozapine has been a revolutionary pharmacological step for treating psychotic patients as …

Revealing G‐protein‐coupled receptor oligomerization at the single‐molecule level through a nanoscopic lens: methods, dynamics and biological function

…, S Aringhieri, A Radenovic, GU Corsini… - The FEBS …, 2016 - Wiley Online Library
The introduction of super‐resolution fluorescence microscopy has allowed the visualization
of single proteins in their biological environment. Recently, these techniques have been …

[HTML][HTML] D2/D3 dopamine receptor heterodimers exhibit unique functional properties

…, R Lin, A Baragli, A Colzi, N Griffon, GU Corsini… - Journal of Biological …, 2001 - ASBMB
Evidence for heterodimerization has recently been provided for dopamine D 1 and adenosine
A 1 receptors as well as for dopamine D 2 and somatostatin SSTR 5 receptors. In this …

Nicotine prevents experimental parkinsonism in rodents and induces striatal increase of neurotrophic factors

…, M Armogida, G Racagni, GU Corsini - Journal of …, 1998 - Wiley Online Library
The repeated finding of an apparent protective effect of cigarette smoking on the risk of
Parkinson's disease is one of the few consistent results in the epidemiology of this disorder. …

The impact of G‐protein‐coupled receptor hetero‐oligomerization on function and pharmacology

R Maggio, F Novi, M Scarselli, GU Corsini - The FEBS journal, 2005 - Wiley Online Library
Although highly controversial just a few years ago, the idea that G‐protein‐coupled receptors
(GPCRs) may undergo homo‐oligomerization or hetero‐oligomerization has recently …

Therapeutic efficacy of apomorphine combined with an extracerebral inhibitor of dopamine receptors in Parkinson's disease

GU Corsini, M Del Zompo, GL Gessa, A Mangoni - The Lancet, 1979 - Elsevier
Apomorphine in combination with a peripheral dopamine receptor blocker (domperidone)
was administered to four parkinsonian patients in a double-blind placebo-controlled study. …

[HTML][HTML] Repurposing the mucolytic cough suppressant and TMPRSS2 protease inhibitor bromhexine for the prevention and management of SARS-CoV-2 infection

R Maggio, GU Corsini - Pharmacological research, 2020 - ncbi.nlm.nih.gov
Bromhexine is an over-the-counter mucolytic cough suppressant that was introduced in 1963
under the trademark of Bisolvon®. It is a widely prescribed drug for treatment of a range of …

Effects of noradrenergic lesions on MPTP/MPP+ kinetics and MPTP-induced nigrostriatal dopamine depletions

…, MT Torracca, L Bassi, GU Corsini - … of Pharmacology and …, 1997 - ASPET
Norepinephrine (NE) depletion caused by damage to locus ceruleus neurons was shown to
worsen experimental Parkinsonism induced by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-…

MK‐801 prevents 1‐methyl‐4‐phenyl‐1, 2, 3, 6‐tetrahydropyridine‐induced parkinsonism in primates

…, F Fascetti, F Fornai, GU Corsini - Journal of …, 1992 - Wiley Online Library
In cynomologus monkeys, systemic administration of MK‐801, a noncompetitive antagonist
for the N‐methyl‐4‐aspartate receptor, prevented the development of the parkinsonian …

Increased susceptibility to kainic acid–induced seizures in Engrailed-2 knockout mice

…, S Casarosa, HH Simon, F Vaglini, GU Corsini… - Neuroscience, 2009 - Elsevier
The En2 gene, coding for the homeobox-containing transcription factor Engrailed-2 (EN2),
has been associated to autism spectrum disorder (ASD). Due to neuroanatomical and …